CRPC
Clinical trials for CRPC explained in plain language.
Never miss a new study
Get alerted when new CRPC trials appear
Sign up with your email to follow new studies for CRPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat prostate cancer: enhertu trial launches
Disease control Recruiting nowThis phase 2 trial tests Enhertu, a targeted drug, in 60 men with HER2-positive prostate cancer that has spread and stopped responding to hormone therapy and newer drugs like abiraterone. Participants must have tried or refused chemotherapy. The study measures tumor shrinkage and…
Matched conditions: CRPC
Phase: PHASE2 • Sponsor: Washington D.C. Veterans Affairs Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for advanced cancers? JAB-8263 enters human testing
Disease control Recruiting nowThis study tests a new drug called JAB-8263 in adults with advanced solid tumors or blood cancers that have stopped responding to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 152 people will take part in this early-phase trial.
Matched conditions: CRPC
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC